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INTRODUCTION:  Intussusception  is  a rare  disease  in adults  and  poses  a  challenge  to identify  and  manage.
In  adults,  surgical  resection  is  the  preferred  treatment  since  half  are  due  to  malignancy.  This  case  reveals
an association  between  highly  active  antiretroviral  therapy  (HAART)  and intussusception.
PRESENTATION  OF  CASE:  A 44  year-old  female  with  history  of HIV  on highly  active  antiretroviral  therapy
(HAART)  presented  with  3 month  history  of  epigastric  pain,  nausea,  emesis,  weight  loss,  and  lactic  acido-
sis.  CT  of  abdomen  showed  two  small  bowel  intussusceptions  and  pericolic  fat inﬁltration.  A  diagnosis  of
mitochondrial  toxicity  secondary  to HAART  medication  was  made.  HAART  medication  was  discontinued
with  resolution  of  symptoms.  Further  work-up  to exclude  a mechanical  cause  for  her symptoms  including
colonoscopy,  small  bowel  follow  through,  esophagogastroduodenoscopy,  and  repeat CT were  performed.
All established  an  absence  of  malignancy  and  intussusception.
DISCUSSION:  Mitochondrial  toxicity  (MT) is a well-known  complication  of  HAART.  A  hallmark  of  MT
is  lactic  acidosis  which  when  untreated  can  be fatal.  Although  MT  is known  to  cause  gastrointestinal
symptoms,  intussusception  has  not  been  previously  reported.  In  our  patient  with  MT, prolonged  usage
of  HAART  medication  resulted  in  severe  gastrointestinal  symptoms  and  intussusception  mimicking  a
surgical  abdomen.  Laparotomy  has been  recommended  on adult  patients  with  intussusceptions  because
of the high  likelihood  of  identifying  a pathologic  lesion.  The  doctrine  of adult  intussusception  is to operate
for  concern  of  malignancy.
CONCLUSION: Surgeons,  gastroenterologist  and  internist  caring  for  patients  on  HAART  therapy  must be
aware  of the possibility  of  MT  when  evaluating  HIV patients  for possible  surgical  abdomen.
©  2015  Published  by Elsevier  Ltd.  on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
he  CCunder  t
. Introduction
Intussusception is a rare disease in the adult population and
an be difﬁcult to diagnosis and treat. It represents only 1% of all
owel obstructions [1,2] . About 0.003–0.02% of all hospital admis-
ion are due to intussusception. Due to its rarity in adults, it poses
 challenge to identify and manage. In adults, surgical resection of
he intussusception without reduction is the preferred treatment
ince approximately half are due to malignancy. We  present here
n unusual case of intussusception in an adult patient with human
mmunodeﬁciency virus (HIV) who developed intussusception sec-
ndary to highly active antiretroviral therapy (HARRT) manifesting
s a pseudo-surgical abdomen.
. Case presentationA 44 year-old female with past medical history of human
mmunodeﬁciency virus (HIV) on highly active antiretroviral ther-
py (HAART) was referred to the gastroenterologist for a 6 month
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history of epigastric pain associated with nausea, vomiting, and
an unintentional 37 lb weight loss. She denied diarrhea or changes
in her bowel movements. Her last CD4 count was >200 with a
viral load of 33,000. She underwent a computed tomography (CT)
of abdomen with oral and IV contrast which revealed two  intus-
susceptions of the small bowel as well as circumferential fat halo
within the descending colon, sigmoid colon, and rectal walls rais-
ing concern for new onset of inﬂammatory bowel disease [Fig. 1].
However before she could follow-up the pain worsened which
prompted her to present to the Emergency Department.
In the emergency room her vital signs were within normal
limits. Abdominal examination was  signiﬁcant for epigastric ten-
derness. Her labs were unremarkable and an abdominal X-ray
was unremarkable. She was given intravenous ﬂuids and Meto-
clopramide 10 mg  IV and discharged home with a prescription for
Zantac 150 mg  twice a day. However she returned to the Emergency
Department ﬁve days later with similar symptoms and inability
to tolerate anything by mouth associated with non-bloody diar-
rhea. Again her vital signs were within normal limits and abdominal
examination showed similar epigastric tenderness. She underwent
a repeat computed tomography (CT) of abdomen with contrast
which revealed a recurrent short segment of a non-obstructing
intussusception of the small bowel [Fig. 2]. She was again given
is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 1. Initial computed tomography (CT) scan of the abdomen. Cross-sectional
image of the mid  portion of two intussusceptions (arrows) illustrates small bowel
invagination of the small bowel. No evidence of bowel obstruction.


























ever in the small intestine, intussusception is more likelymage of the mid  portion of again shows recurrent short segment non-obstructing
ntussusception of the small bowel (arrow).
ntravenous ﬂuids and Metoclopramide 10 mg  IV and discharged
ome.
Five days later she represented to the Emergency department
ith complaints of worsening abdominal pain, muscle pain and
eakness, post-prandial vomiting and fatigue. Vital signs were
igniﬁcant for tachycardia and mild hypotension. Exam revealed
 thin, ill-appearing woman, with dry mucus membranes, and a
oftly distended abdomen with moderate upper abdominal ten-
erness. Computed tomography (CT) of abdomen with contrast no
onger visualized the previously seen intussusception [Fig. 3] but
emonstrated edematous jejunal loops and diffuse deposition of
at in the colon with pericolic stranding and edema. Laboratory
tudies revealed a lactate of 4.6 mmol/L. The gastroenterologist
ecommended surgical consultation for consideration of surgical
xploration and resection of the obstructing segment. The patient
as admitted to the acute care surgery service with the differential
iagnosis of dehydration, inﬂammatory bowel disease, or malig-
ancy such as lymphoma.
Initial management was gastric decompression with nasogastric
ube and intravenous ﬂuid resuscitation. She remained unable to
olerate oral intake although a small bowel follow-through (SBFT)
as unable to demonstrate mechanical occlusion. During the fol-owing days despite adequate ﬂuid resuscitation a repeat lactate
evel was again abnormally high at 5.7 mmol/L. A source for type B
actic acidosis was entertained. A metabolic source was  excludedFig. 3. Third computed tomography (CT) scan of the abdomen. The jejunal loops
remain edematous but no further intussusceptions.
and drug toxicity or malignancies were considered the most likely
sources. Upon further questioning the patient noted that shortly
after a change in her HIV medications she was  diagnosed with
hypomotility and started on the prokinetic agent Doperidone. Her
HAART medication was discontinued resulting in normalization of
her lactate and regression of her symptoms.
She eventually underwent a ﬂexible sigmoidoscopy, small
bowel follow through (SBFT), and esophagogastroduodenoscopy
(EGD). Her ﬂexible sigmoidoscopy revealed normal appearing
colonic mucosa with biopsies of sigmoid and rectum showing
normal colonic mucosa. Further her SBFT was performed to eval-
uate proximal bowel which showed healthy bowel including both
normal transit time and mucosa. Lastly, her EGD only revealed non-
erosive gastritis. Capsule endoscopy was  considered however with
symptoms completely resolved and all other diagnosistic workup
negative, there was a low indication. Eventually the patient was
advanced to a regular diet with no further abdominal pain or eme-
sis, and discharged home with follow-up over the past year showing
no further lactic acidosis or intestinal complaints.
3. Discussion
Intussusception was ﬁrst reported by Barbette of Amsterdam
in 1674 [1] who not only described the intestinal invagination but
also the possibility of surgical reduction. Hunter [2] later deﬁned
intussusception as a rare form of bowel obstruction in the adult,
which is the telescoping of proximal segment of bowel into a dis-
tal segment. However the ﬁrst successful surgical correction of an
intussusception was not described until 1871 by Hutchinson [3].
Today it is the most common abdominal emergency in children
younger than two years of age [4], however in adults it’s rarely
seen. The child to adult ratio is more than 20:1 [5]. Intussuscep-
tion in children is usually primary and idiopathic [6], while adults
usually have intussusceptions secondary to an organic lesion in
about 70–90% of cases of which about 20–50% of these cases are
due to malignancy [7]. However it has yet to be associated with
antiretroviral medications as was  seen in this case.
In the colon, intussusceptions is most commonly caused by
malignancy, metastatic lesions (from melanoma, breast and lung),
leimyosarcomas, malignant ﬁbrous histocytomas, lymphomas,
carcinoid tumors, adenocarcinoma, Peutz–Jeghers syndrome,
Henoch-Schönlein purpura, celiac disease, Crohn’s disease. How-secondary to benign lesions, inﬂammatory ﬁbrous polyps, lipomas,
leiomyomas, haemangioma, or Meckel’s diverticula. Some other
reported causes of intussusceptions in adults include trauma and
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perative factors (anastomosis sites, adhesions, suture lines, and
eeding jejunostomy) [9]. Further adult intussusceptions can be
ssociated with a systemic disease, such as AIDS.
Cases of adult intussusceptions have been commonly reported
n HIV patients [10–12]. Wood et al. reported in their study that
IV- and AIDS-associated gastrointestinal pathology provide lead
oints for intussusception. These patients are at signiﬁcant risk
or intussusception. They conclude that intussusception should
e a diagnostic consideration in an HIV-positive young adult
ith abdominal complaints. Established causes include the cor-
elation between HIV and the increased incidence of pathologic
mall bowel processes [13] including intestinal Karposi-Sarcoma
14], lymphoma or infections [11]. Small bowel processes in AIDS
atients may  act as lead points of intussusceptions. In AIDS patients,
ypersecretory infectious enteritis can cause intrinsic small bowel
nﬂammation and lymphoid hyperplasia. A motility dysfunction
f neuroendocrine origin has been proposed as a mechanism of
ntussusceptions in those cases where no lead point could be found.
However our patient proved to have no evidence of neoplastic or
nﬂammatory causes of intussusception. Instead she was  uniquely
een to have an association between her abdominal ﬁndings and
er highly active antiretroviral therapy (HAART). Since the dawn of
IDS, gastrointestinal symptoms have been a common aspect of the
isease. Despite the advent of HAART in 1995 [18] patients continue
o have gastrointestinal symptoms. Of the toxicities associated with
AART, mitochondrial toxicity is recognized as one of the major
dverse effects of nucleoside analogue treatments [19].
The exact mechanism of HAART toxicity is not completely
nown. Nucleoside analogs inhibit HIV replication due to their high
fﬁnity for viral enzyme reverse transcriptase, thus inhibiting HIV
eplication [20]. These nucleoside reverse transcriptase inhibitors
NRTIs) can also bind to other human DNA-polymerases in the
itochondrial DNA. This in turn leads to the impairment of oxida-
ive phosphorylation which causes energy loss (decreased ATP) and
n increase of electron leakage thus increasing the production of
eactive oxygen species (ROS). As it was seen in our patient, she
resented with a Type B lactic acidosis. With mitochondrial dys-
unction, the metabolism of pyruvate is shifted to lactate with a
ecrease in energy production and cellular dysfunction [21]. This
yperlactatemia usually occurs in the absence of systemic hypop-
rfusion (Type A lactic acidosis). Clinical manifestations of these
ellular events include lipodystrophy, myopathy, peripheral neu-
opathy, lactic acidosis, and hepatic steatosis. Left unrecognized
eath will ensue.
Intussusception has not been reported as a common effect of the
edication. There have been reports of hepatic toxicity and gas-
rointestinal motility issues [22], yet this case report presents the
rst of its kind of HAART toxicity associated with intussusception.
One key to the diagnosis of mitochondrial toxicity in our patient
as the recognition of a chronic lactic acidosis. Lactic acidosis has
een classiﬁed by Cohen and Woods into 4 types [23,24]. Type
 is hyperlactatemia caused by hypoperfusion and hypooxygena-
ion as seen in shock states. Type B hyperlactatemia has three
urther subdivisions. Type B-1 is caused by systemic metabolic con-
itions such as diabetes, renal insufﬁciency, hepatic insufﬁciency
r malignancies, especially leukemia and lymphoma. Type B-2
yperlactatemia is secondary to drug toxicity. Well known exam-
les include cyanide, phenformin, ethanol and now anti-retrovirals
sed in the treatment of HIV. Type B 3 are those hyperlactatenemias
econdary to congenital metabolic disorders such as in pyruvate
ehydrogenase deﬁciency.
This patient with a history of HIV on HAART, presented
rst with symptoms of enteral dysmotility which advanced to
ntussusception and a surgical abdomen. Initial resuscitation and
iscontinuation of HAART medications on the suspicion of mito-
hondrial toxicity were important steps in the recovery of this
[PEN  ACCESS
rgery Case Reports 18 (2016) 33–36 35
patient. However given the risk of malignancy in this population
we adhered and recommend that the algorithms for diagnosis and
exclusion of a pathologic lesion be followed. Although CT is the most
utilized diagnostic tool, studies have shown the beneﬁt of barium
enema tests with a diagnostic rate from 54 to 95% [17]. Despite
the presentation of a surgical abdomen, the patient was noted to
improve with the cessation of HAART. With this conservative man-
agement, the intussusceptions rapidly resolved both clinically and
on imaging.
In our patient, it was  seen that HAART medication, associ-
ated with mitochondrial toxicity caused both a lactic acidosis
and intussusception. This is a unique case in which prolonged
unrecognized toxicity caused by a HAART regimen resulted in
severe gastrointestinal symptoms and intussusceptions mimick-
ing a surgical abdomen. Laparotomy has been recommended on
adult patients with intussusception because of the likelihood of
identifying a pathologic lesion. It is imperative that the surgeon,
gastroenterologist and internist caring for patients on HAART ther-
apy are aware of the possibility of mitochondrial toxicity when
evaluating HIV patients for possible surgical abdomen. This case
challenges the doctrine of surgical intervention for all cases of
intussusception particularly in the HIV patient who may be spared
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